Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Grows By 454.0%

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 2,510,000 shares, a growth of 454.0% from the May 31st total of 453,100 shares. Based on an average daily trading volume, of 4,190,000 shares, the days-to-cover ratio is presently 0.6 days. Approximately 29.2% of the shares of the stock are sold short.

Aethlon Medical Stock Performance

Shares of Aethlon Medical stock traded down $0.05 on Friday, reaching $0.53. 747,689 shares of the stock were exchanged, compared to its average volume of 2,235,995. The firm has a market cap of $1.39 million, a PE ratio of -0.12 and a beta of 1.60. The firm’s 50 day moving average is $0.80 and its 200-day moving average is $1.45. Aethlon Medical has a one year low of $0.37 and a one year high of $5.00.

Analyst Upgrades and Downgrades

AEMD has been the subject of several analyst reports. HC Wainwright dropped their price objective on Aethlon Medical from $10.00 to $7.00 and set a “buy” rating for the company in a report on Monday. StockNews.com began coverage on Aethlon Medical in a research note on Sunday, June 23rd. They issued a “sell” rating for the company.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.